U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07629557) titled 'Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus' on June 01.
Brief Summary: Clinical trial to evaluate the safety and feasibility of corneal cross-linking in both eyes on the same day in subjects with keratoconus.
Study Start Date: May 11
Study Type: INTERVENTIONAL
Condition:
Keratoconus
Intervention:
DRUG: Riboflavin Ophthalmic Solutions
Riboflavin Ophthalmic Solutions
DEVICE: UV-A Irradiation System
O2n UV-A Irradiation System
Recruitment Status: RECRUITING
Sponsor: Glaukos Corporation
Published by HT Digital Content Services with permission from Health Daily...